Corteva, Inc. (CTVA) Business Profile

What it does

Corteva is an agricultural inputs company that sells seeds, seed technologies and crop protection products used by farmers. It was founded on 2018-03-15 and is headquartered in Washington, D.C. Charles V. Magro is its chief executive officer.

The company operates through Seed and Crop Protection. Seed develops and supplies commercial seeds combining plant genetics, known as germplasm, with traits intended to help crops withstand weather, pests, diseases and herbicides. Its brands include Pioneer and Brevant. Corteva also licenses seed traits and germplasm to other businesses and offers digital tools to help farmers select products and make growing decisions.

Crop Protection sells products that control weeds, insects and diseases, along with nitrogen management products and treatments applied to seeds. Its portfolio also includes biological and other nature-based products. Farmers can obtain Corteva products through channels including independent representatives, regional seed brands and agricultural retailers.

Corteva intends to separate Seed and Crop Protection into two publicly traded companies. It has named the future seed and genetics business Vylor and is targeting October 1, 2026 for the separation, subject to completing remaining milestones.

How it makes money

Corteva earns revenue by selling seed and crop protection products and by licensing seed technology. Seed combines plant genetics with traits designed for particular growing conditions. The business sells through its own brands and licenses traits and germplasm to third parties. Its products include Enlist E3 soybeans and corn technologies, as well as seed treatments.

Crop Protection sells herbicides, insecticides, disease-control products, nitrogen stabilizers, biologicals and seed-applied technologies. These products address different stages and problems in the growing cycle. Corteva generally formulates crop protection products close to end customers.

Sales follow the agricultural calendar: Corteva typically generates about 60 percent of its sales in the first half of the calendar year, driven by northern hemisphere Seed and Crop Protection sales, and about 40 percent in the second half, led by southern hemisphere Seed sales. Farmers make purchases around planting and growing seasons, while licensing also generates royalty income. Planting delays can affect the timing and mix of sales.

For the year ended December 31, 2025, net sales were $17,401 million; for the first half of 2026, net sales were $11.3 billion.

In the first half of 2026, Corteva reported higher seed royalty income and said competitive market conditions pressured crop protection pricing, particularly in Latin America. The company said crop protection pricing declined low single digits while volumes increased low single digits, primarily on demand for new products.

Customers and how it sells

Corteva serves farmers globally, both directly and through intermediaries. Its seed network includes the Pioneer agency model, regional seed brands, retail and third-party licensing and distribution. Independent sales representatives make Pioneer sales directly to farmers and interact with them through the growing season. Regional brands use employees and farmer-dealer networks; retail channels can include distributors, agricultural cooperatives and dealers.

The Seed business serves markets including North American corn and soybeans, European corn and sunflower, and corn markets in Brazil, India, South Africa and Argentina. In Brazil, Corteva is pursuing adoption of Conkesta E3 soybean technology through licensing. Crop Protection serves the global agricultural input industry.

Sales timing differs by hemisphere. Northern hemisphere planting drives much of the first half, while southern hemisphere seed sales lead the second half. Corteva has said tight credit and fuel and fertilizer costs are putting pressure on Brazilian growers, causing some purchasing decisions to move closer to planting.

Corteva employed approximately 21,500 people globally as of December 31, 2025. Its customer-facing network and workforce span North America, Latin America, EMEA and Asia-Pacific.

Suppliers and costs

Seed production depends on corn and soybean seeds and on third-party growers around the world. Corteva contracts with growers to produce seed near customers and uses both its own plants and third-party contract plants to condition and package it. The company also licenses biotechnology traits from third parties; most corn hybrids and soybean varieties it sells contain traits obtained under long-term licenses.

Crop Protection uses materials including chlorinated pyridine derivatives, specialty intermediates, technical-grade active ingredients, chlorine and seed treatments. Corteva generally buys major raw materials under long-term contracts with multiple suppliers, sometimes with minimum purchase commitments. A few major suppliers provide certain important materials. Contract manufacturers produce some inputs and components, while Corteva generally formulates products close to customers.

Cost of goods sold was $9,172 million for the year ended December 31, 2025. Corteva said lower raw material and commodity costs, productivity actions and reduced net royalty expense contributed to the decline from the prior year. It is restructuring parts of its Crop Protection manufacturing network and expects the actions to be substantially complete by the end of 2026.

Competitive position

Corteva competes globally with seed germplasm producers, trait developers and crop protection companies. It identifies BASF, Bayer, FMC, Syngenta and ChemChina as key competitors, along with regional seed companies and businesses selling generic crop protection chemicals. Corteva competes on genetics and traits, price, quality and costs.

Corteva considers its patents, trade secrets, trademarks and copyrights collectively important to protecting its research and development investment. It also says no single patent, trademark, license or related group is essential to the company as a whole or to either segment. Its Pioneer agency model gives it direct contact with farmers during the growing season, and it licenses traits and germplasm to third parties.

Our reading: Corteva’s genetics, traits and intellectual property provide a meaningful competitive advantage because they support both branded seed sales and licensing, although the company also relies on third-party trait licenses. (item1)

Our reading: Direct farmer relationships are another source of differentiation, giving Corteva opportunities to provide advice and learn about ordering decisions; they do not remove exposure to price competition. (item1)

Corteva said crop protection faced competitive pricing pressure in the first half of 2026, particularly in Latin America. It also said some of its active ingredients face competition as patents expire.

Growth opportunities

Corteva’s Seed business plans to pursue growth through gene editing, biofuels, hybrid wheat, expanded crop offerings, licensing and acquisitions. It is also seeking to expand Conkesta E3 soybean adoption in Brazil through licensing. The company says its seed licensing business is ahead of its original plan.

Crop Protection plans to grow through its product portfolio, including biologicals, and through acquisitions and operational improvements. Corteva says it has seven new crop protection active ingredients coming to market over the next decade. It also says new products contributed to volume growth in the first half of 2026.

Corteva is preparing to separate the businesses, with Vylor becoming the standalone seed and genetics company. The company is targeting October 1, 2026 for the separation, assuming remaining milestones are completed. Those steps include finalizing capital structures and completing remaining information technology separation activities.

For 2026, Corteva expects operating EBITDA between 4.1 and 4.3 billion. It expects seed organic sales growth in the low single digits and crop protection volumes to grow at a high single-digit rate in the second half, while crop protection pricing declines in the low to mid single digits.

Structural risks

• Regulatory approvals: Seed biotechnology and crop protection products require testing and approval in individual markets. Delays, changing standards, bans or invalidated registrations could restrict sales, increase costs or reduce returns on research and development.
• Product development: New seeds, traits and crop protection products take time to develop, and only a small proportion of tested chemicals, genes and germplasm reach commercialization. Technical problems, regulatory obstacles, competition or insufficient demand can prevent launches.
• Weather and seasonality: Sales are concentrated around planting seasons. Unfavorable weather can delay planting and change quarterly sales and product mix; severe weather can affect overall sales.
• Costs and supply: Input cost volatility can affect results. Corteva depends on third-party growers, suppliers, contract manufacturers and licenses, and some important crop protection materials come from only a few major suppliers.
• Competition and customer credit: Generic products and other competitors put pressure on pricing. Customers may also be unable to pay their debts to Corteva.
• Separation: The proposed spin-off may not be completed on the contemplated timeline or at all, and may not achieve its intended benefits. It can also divert management attention and bring unexpected costs or litigation.

Bottom line

Our reading

Our reading: Corteva combines recurring agricultural demand with technology development, branded distribution and licensing, but its sales remain tied to planting seasons and weather. (item1; item7)

Our reading: Its opportunity rests on bringing new seed traits and crop protection products to market and expanding licensing; regulation, generic competition, input costs and the planned separation are material exposures. (item1; item1a; call_qa)